• NVP-BGJ398 Phosphate: Precision Inhibition of FGFR for Rare

  2026-06-11

  Explore how NVP-BGJ398 phosphate enables targeted FGFR pathway inhibition in both cancer and skeletal disease models. This article provides advanced scientific guidance, integrating novel in vivo insights and practical assay strategies to support researchers using this selective pan-FGFR inhibitor.

• EPI-001: Advanced Workflows for Androgen Receptor N-Terminal

  2026-06-11

  EPI-001 delivers precise inhibition of androgen receptor signaling by targeting the N-terminal domain, enabling researchers to dissect both ligand-dependent and independent pathways in prostate and breast cancer models. This guide details evidence-driven workflows, troubleshooting strategies, and practical insights for maximizing experimental reproducibility with this small-molecule AR inhibitor.

• A40926 (SKU BA1486): Reliable Solutions for Antibacterial As

  2026-06-10

  This article presents scenario-driven, evidence-based guidance for deploying A40926 (SKU BA1486) in Gram-positive bacterial infection research and in vitro antibacterial assays. It addresses real laboratory challenges—including assay sensitivity, MIC determination, and vendor reliability—offering actionable solutions and protocol parameters for researchers seeking robust, reproducible results with A40926.

• iPSC-Based Multimodal Drug Testing for Cystic Fibrosis: Adva

  2026-06-10

  This study introduces a multimodal platform using iPSC-derived airway epithelial cells to model diverse CFTR variants in cystic fibrosis, enabling genotype-specific drug testing. By adapting established functional assays, the research provides a scalable, patient-relevant approach for preclinical therapeutic evaluation, especially for rare CFTR mutations.

• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-06-09

  This study systematically characterizes the prevalence, genetic localization, and transferability of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong province during the COVID-19 era. The findings reveal high rates of multidrug resistance, dominant plasmid-mediated blaNDM-1 carriage, and complex transmission patterns, highlighting important implications for antimicrobial resistance research and infection control.

• Pharmacokinetics of Corydalis saxicola Alkaloids in MASH Mod

  2026-06-09

  This study systematically characterizes the pharmacokinetic variability and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mice with metabolic dysfunction-associated steatohepatitis (MASH) induced by a high-fat, high-cholesterol diet. By integrating transporter and metabolic enzyme modulation analysis, the research provides mechanistic insight into how disease status alters CSBTA disposition, informing rational dosage strategies for MASLD/MASH therapy.

• 4-Ethylphenyl Sulfate: Optimizing Gut-Brain and Renal Assays

  2026-06-08

  4-Ethylphenyl sulfate is revolutionizing research into gut microbiota-brain interactions and renal dysfunction biomarkers. This guide delivers actionable workflows, troubleshooting strategies, and advanced surface science insights that maximize the experimental value of APExBIO’s high-purity reagent.

• Alda 1: Redefining ALDH2 Activation for Precision Cardioprot

  2026-06-08

  Explore how Alda 1, a potent ALDH2 activator, enables breakthrough cardioprotection and aldehyde detoxification in ischemic models. This article uniquely deciphers its mechanistic advantages and experimental insights for advanced cardiac research.

• SP600125: Redefining JNK Inhibition for Translational Impact

  2026-06-07

  This article explores the mechanistic and translational landscape of SP600125, a selective JNK inhibitor, highlighting its pivotal role in apoptosis, inflammation, and cytokine modulation. We bridge the latest kinase-substrate mapping insights with actionable strategy for translational scientists and position SP600125 from APExBIO as a next-generation tool for pathway dissection and preclinical innovation.

• Oridonin Suppresses Inflammation in Esophageal Cancer Models

  2026-06-06

  This study elucidates how oridonin inhibits esophageal cancer progression by targeting the TLR4/NF-κB/NLRP3 inflammasome pathway in a murine model. The findings provide mechanistic clarity and a benchmark for anti-inflammatory research in oncology, with direct implications for metabolic and protease assay optimization.

• Octyl-α-ketoglutarate: Enhancing Prolyl Hydroxylase Substrat

  2026-06-05

  Octyl-α-ketoglutarate empowers researchers to precisely manipulate intracellular α-ketoglutarate levels, enabling robust interrogation of hypoxia signaling and metabolic reprogramming. Its cell-permeable, stable design from APExBIO streamlines protocols in TCA cycle dysfunction and IDH mutation metabolic studies, with clear advantages for troubleshooting HIF-1α regulation.

• Clasto-Lactacystin β-lactone: Proteasome Inhibitor Workflows

  2026-06-05

  Clasto-Lactacystin β-lactone offers unmatched specificity and potency for dissecting ubiquitin-proteasome pathway regulation in cancer, neurodegeneration, and viral immunology. This guide details optimized experimental workflows, troubleshooting strategies, and practical insights drawn from recent studies to maximize the utility of this irreversible proteasome inhibitor.

• Rapamycin-Induced Autophagy Mitigates Lipotoxicity in Salmon

  2026-06-04

  This study demonstrates that autophagy activation via rapamycin enhances lipid breakdown and reduces lipotoxicity in Atlantic salmon macrophage-like cells. The work establishes conserved mechanisms of autophagy-mediated lipid regulation in fish, with implications for aquaculture health management.

• Regulatory Gene Engineering Enhances A40926 Antibiotic Produ

  2026-06-04

  This study investigates the capacity of heterologous StrR-like pathway-specific regulators from ramoplanin and chersinamycin gene clusters to modulate glycopeptide antibiotic biosynthesis, specifically teicoplanin and A40926. The findings reveal that certain regulatory genes, when introduced into native producers, significantly boost antibiotic yields—offering new strategies for activating silent biosynthetic pathways and optimizing production in antibiotic research.

• MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazoliu

  2026-06-03

  Unlock the full potential of MTT as a gold-standard colorimetric cell viability assay reagent. This guide integrates experimental workflows, advanced troubleshooting, and real-world insights—empowering research with robust, reproducible results.

452 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page